Search Results - "Savitz, J"

Refine Results
  1. 1

    Neuropathology of mood disorders: do we see the stigmata of inflammation? by Mechawar, N, Savitz, J

    Published in Translational psychiatry (08-11-2016)
    “…A proportion of cases with mood disorders have elevated inflammatory markers in the blood that conceivably may result from stress, infection and/or…”
    Get full text
    Journal Article
  2. 2

    Clinical application of brain imaging for the diagnosis of mood disorders: the current state of play by Savitz, J B, Rauch, S L, Drevets, W C

    Published in Molecular psychiatry (01-05-2013)
    “…In response to queries about whether brain imaging technology has reached the point where it is useful for making a clinical diagnosis and for helping to guide…”
    Get full text
    Journal Article
  3. 3

    The molecular genetics of cognition: dopamine, COMT and BDNF by Savitz, J., Solms, M., Ramesar, R.

    Published in Genes, brain and behavior (01-06-2006)
    “…The important contribution of genetic factors to the development of cognition and intelligence is widely acknowledged, but identification of these genes has…”
    Get full text
    Journal Article
  4. 4

    Imaging phenotypes of major depressive disorder: genetic correlates by Savitz, J.B, Drevets, W.C

    Published in Neuroscience (24-11-2009)
    “…Abstract Imaging techniques are a potentially powerful method of identifying phenotypes that are associated with, or are indicative of, a vulnerability to…”
    Get full text
    Journal Article
  5. 5

    Serum kynurenic acid is reduced in affective psychosis by Wurfel, B E, Drevets, W C, Bliss, S A, McMillin, J R, Suzuki, H, Ford, B N, Morris, H M, Teague, T K, Dantzer, R, Savitz, J B

    Published in Translational psychiatry (02-05-2017)
    “…A subgroup of individuals with mood and psychotic disorders shows evidence of inflammation that leads to activation of the kynurenine pathway and the increased…”
    Get full text
    Journal Article
  6. 6

    Efficacy and Safety of Paliperidone Extended Release in Adolescents With Schizophrenia: A Randomized, Double-Blind Study by Savitz, Adam J., MD, PhD, Lane, Rosanne, MAS, Nuamah, Isaac, PhD, Gopal, Srihari, MD, MHS, Hough, David, MD

    “…Objective To evaluate the efficacy, safety, and tolerability of paliperidone extended release (ER) relative to aripiprazole in adolescent schizophrenia. Method…”
    Get full text
    Journal Article
  7. 7

    Efficacy and safety of paliperidone palmitate 3-month formulation in Latin American patients with schizophrenia: A subgroup analysis of data from two large phase 3 randomized, double-blind studies by Savitz, Adam J, Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Mathews, Maju, Soares, Bernardo

    Published in Revista brasileira de psiquiatria (01-11-2019)
    “…To analyze the efficacy and safety of paliperidone palmitate 3-monthly (PP3M) in Latin American patients with schizophrenia vs. rest-of-world (ROW). We…”
    Get full text
    Journal Article
  8. 8

    Diets of Lake Michigan Salmon and Maximum Size of Alewife Prey by Savitz, J.

    Published in Journal of freshwater ecology (01-12-2009)
    “…The diets of Lake Michigan salmon were determined by examining stomach contents of sport-caught salmon. The study was conducted from 2001 through 2008 when the…”
    Get full text
    Journal Article
  9. 9

    An examination of neurocognition and symptoms as predictors of post-hospital community tenure in treatment resistant schizophrenia by Ahmed, Anthony O, Murphy, Christopher F, Latoussakis, Vassilios, McGovern, Kelly E, English, Judith, Bloch, Andrew, Anthony, Donna T, Savitz, Adam J

    Published in Psychiatry research (28-02-2016)
    “…Abstract Neurocognition and psychopathology are robust predictors of community functioning and relapse/rehospitalization in schizophrenia. Existing studies are…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Personality endophenotypes for bipolar affective disorder: a family‐based genetic association analysis by Savitz, J., Van Der Merwe, L., Ramesar, R.

    Published in Genes, brain and behavior (01-11-2008)
    “…Genetic analyses of complex conditions such as bipolar disorder (BD) may be facilitated by the use of intermediate phenotypes. Various personality traits are…”
    Get full text
    Journal Article
  12. 12

    Opportunities for use of neuroimaging in de-risking drug development and improving clinical outcomes in psychiatry: an industry perspective by Etkin, Amit, Powell, Jessica, Savitz, Adam J.

    Published in Neuropsychopharmacology (New York, N.Y.) (01-11-2024)
    “…Neuroimaging, across positron emission tomography (PET), electroencephalography (EEG), and magnetic resonance imaging (MRI), has been a mainstay of clinical…”
    Get full text
    Journal Article
  13. 13

    Epistasis network centrality analysis yields pathway replication across two GWAS cohorts for bipolar disorder by Pandey, A, Davis, N A, White, B C, Pajewski, N M, Savitz, J, Drevets, W C, McKinney, B A

    Published in Translational psychiatry (14-08-2012)
    “…Most pathway and gene-set enrichment methods prioritize genes by their main effect and do not account for variation due to interactions in the pathway. A…”
    Get full text
    Journal Article
  14. 14

    Clinical relevance of paliperidone palmitate 3-monthly in treating schizophrenia by Mathews, Maju, Gopal, Srihari, Nuamah, Isaac, Hargarter, Ludger, Savitz, Adam J, Kim, Edward, Tan, Wilson, Soares, Bernardo, Correll, Christoph U

    Published in Neuropsychiatric disease and treatment (01-05-2019)
    “…Antipsychotics are the mainstay in schizophrenia management, and long-acting injectable (LAI) antipsychotics contribute to the successful maintenance of…”
    Get full text
    Journal Article
  15. 15

    Abstract # 1755 Sleep disturbance and kynurenine metabolism in a group of currently depressed, previously depressed, and never depressed subjects by Cho, H.J, Savitz, J, Dantzer, R, Teague, T.K, Drevets, W.C, Irwin, M.R

    Published in Brain, behavior, and immunity (01-10-2016)
    “…Sleep disturbance is known to increase inflammation. Inflammation may activate the kynurenine metabolic pathway and increase the synthesis of potentially…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Predictors of achieving remission in schizophrenia patients treated with paliperidone palmitate 3-month formulation by Nash, Abigail I, Turkoz, Ibrahim, Savitz, Adam J, Mathews, Maju, Kim, Edward

    Published in Neuropsychiatric disease and treatment (01-01-2019)
    “…Long-acting injectable (LAI) antipsychotic paliperidone palmitate 3-month formulation (PP3M) is indicated in the United States for the treatment of…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Lateralization of hand skill in bipolar affective disorder by Savitz, J., Van Der Merwe, L., Solms, M., Ramesar, R.

    Published in Genes, brain and behavior (01-11-2007)
    “…Diverse strands of evidence suggest that schizophrenia is associated with an excess of left and mixed handedness, reflecting anomalous cerebral lateralization…”
    Get full text
    Journal Article
  20. 20

    Efficacy and safety of paliperidone palmitate 3-month versus 1-month formulation in patients with schizophrenia: comparison between European and non-European population by Savitz, Adam J, Xu, Haiyan, Gopal, Srihari, Nuamah, Isaac, Ravenstijn, Paulien, Hough, David, Hargarter, Ludger

    Published in Neuropsychiatric disease and treatment (01-01-2019)
    “…This randomized, double-blind (DB), non-inferiority phase 3 study was conducted to assess the efficacy and safety of paliperidone palmitate 3-month (PP3M) vs…”
    Get full text
    Journal Article